16th September 2016
A combination of insulin glargine and lixisenatide helps people with type 2 diabetes reach meal-time blood sugar targets better, according to a new study. The LixiLan-L trial investigated a ...
Recent Developments in Basal Insulin Therapy for Adult Type 2 Diabetes: What do They Mean for Clinical Practice
18th November 2015
For nurses specialising in diabetes